Early treatment of high-risk hospitalized COVID-19 patients with a combination of interferon beta-1b and remdesivir: a phase 2 open-label randomized controlled trial

Bibliographische Detailangaben

Veröffentlicht in:	Clinical infectious diseases 2022-06
Hauptverfasser:	Tam, Anthony Raymond, Zhang, Ricky Ruiqi, Lung, Kwok Cheung, Liu, Raymond, Leung, Ka Yi, Liu, Danlei, Fan, Yujing, Lu, Lu, Lam, Athene Hoi Ying, Chung, Tom Wai Hin, Yip, Cyril Chik Yan, Lo, Jenny, Wu, Alan Ka Lun, Lee, Rodney, Sin, Simon, Ng, Pauline Yeung, Chan, Wai Ming, Shum, Hoi Ping, Yan, Wing Wa, Chan, Jasper Fuk Woo, Cheng, Vincent Chi Chung, Lau, Chak Sing, Kai-Wang, Kelvin, Chan, Kwok Hung, Yuen, Kwok Yung, Hung, Ivan Fan Ngai
Format:	Artikel
Sprache:	eng
Schlagworte:	Major
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!